SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-22-004396
Filing Date
2022-06-15
Accepted
2022-06-15 15:37:01
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nbio_10k.htm   iXBRL 10-K 908722
2 CERTIFICATION nbio_ex311.htm EX-31.1 7093
3 CERTIFICATION nbio_ex312.htm EX-31.2 6912
4 CERTIFICATION nbio_ex321.htm EX-32.1 3683
5 CERTIFICATION nbio_ex322.htm EX-32.2 3570
11 nbio_10kimg5.jpg GRAPHIC 7221
12 nbio_10kimg1.jpg GRAPHIC 2897
  Complete submission text file 0001477932-22-004396.txt   4249898

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20220331.xsd EX-101.SCH 59297
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20220331_lab.xml EX-101.LAB 289880
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20220331_cal.xml EX-101.CAL 36666
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20220331_pre.xml EX-101.PRE 245183
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20220331_def.xml EX-101.DEF 151536
57 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10k_htm.xml XML 493727
Mailing Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960
Business Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55299 | Film No.: 221017668
SIC: 2834 Pharmaceutical Preparations